Literature DB >> 6202280

The glycoprotein nature of murine gamma interferon.

E A Havell, G L Spitalny.   

Abstract

Synthesis of murine gamma interferon (MuIFN gamma) by phytohemagglutinin (PHA)-stimulated spleen cells was inhibited in a dose-dependent manner by graded concentrations of tunicamycin or 2-deoxy-glucose, both of which inhibit glycosylation. The homologous (murine) and heterologous (rat) antiviral activities of the MuIFN gamma preparations secreted in the presence of the various concentrations of either glycosylation inhibitor were reduced to similar degrees. MuIFN gamma synthesized in the presence of tunicamycin (tunicamycin-MuIFN gamma) exhibited a lower molecular weight (MW), a lack of binding to immobilized Concanavalin-A (Con A), and different charge properties when compared to MuIFN gamma produced in absence of inhibitor (control-MuIFN gamma). Potent rabbit and rat neutralizing antibodies raised against a control-MuIFN gamma subcomponent, isolated by its specific binding to a Con A affinity column, neutralized the antiviral activity of tunicamycin-MuIFN gamma to the same degree as the immunogen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202280     DOI: 10.1007/bf01310659

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  19 in total

1.  Interferon: purification and initial characterization from human diploid cells.

Authors:  E Knight
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

2.  Antigenicity of mouse interferons: distinct antigenicity of the two L cell interferon species.

Authors:  Y Yamamoto; Y Kawade
Journal:  Virology       Date:  1980-05       Impact factor: 3.616

3.  Effect of tunicamycin on the physical properties and antiviral activities of murine L cell interferon.

Authors:  E A Havell; W A Carter
Journal:  Virology       Date:  1981-01-15       Impact factor: 3.616

4.  Nonglycosylated mouse L cell interferon produced by the action of tunicamycin.

Authors:  J Fujisawa; Y Iwakura; Y Kawade
Journal:  J Biol Chem       Date:  1978-12-25       Impact factor: 5.157

5.  Apparent dispensability of the carbohydrate moiety of human interferon for antiviral activity.

Authors:  S Bose; D Gurari-Rotman; U T Ruegg; L Corley; C B Anfinsen
Journal:  J Biol Chem       Date:  1976-03-25       Impact factor: 5.157

6.  Two molecular weight species of murine gamma interferon.

Authors:  E A Havell; G L Spitalny
Journal:  Virology       Date:  1983-09       Impact factor: 3.616

7.  Interferon: evidence for its glycoprotein nature.

Authors:  F Dorner; M Scriba; R Weil
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

8.  Molecular cloning of human immune interferon cDNA and its expression in eukaryotic cells.

Authors:  R Devos; H Cheroutre; Y Taya; W Degrave; H Van Heuverswyn; W Fiers
Journal:  Nucleic Acids Res       Date:  1982-04-24       Impact factor: 16.971

9.  Two antigenically distinct species of human interferon.

Authors:  E A Havell; B Berman; C A Ogburn; K Berg; K Paucker; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

10.  Enhanced production of murine interferon gamma by T cells generated in response to bacterial infection.

Authors:  E A Havell; G L Spitalny; P J Patel
Journal:  J Exp Med       Date:  1982-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.